{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:39:59Z","timestamp":1769636399306,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 2020 annual Congress of the European Society of Cardiology (ESC) was the first ever to be held virtually. Under the spotlight of \u2018the cutting edge of cardiology\u2019, exciting and ground-breaking cardiovascular (CV) science was presented both in basic and clinical research. This commentary summarizes essential updates from ESC 2020\u2014The Digital Experience. Despite the challenges that coronavirus disease 2019 (COVID-19) has posed on the conduct of clinical trials, the ESC Congress launched the results of major studies bringing innovation to the field of general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. In addition to three new ESC guidelines updates, the first ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease were presented. As former ESC president, Professor Casadei undoubtedly pointed out the\u00a0ESC Congress 2020 was a great success. During the ESC 2020 Congress, <jats:italic>BMC Cardiovascular Disorders<\/jats:italic> updated to seven journal sections including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital health, Hypertension and Vascular biology, Primary prevention and CV Risk, and Structural Diseases, Heart Failure, and Congenital Disorders. To conclude, an important take-home message for all CV health care professionals engaged in the COVID-19 pandemic is that we must foresee and be prepared to tackle the dramatic, long-term CV complications of COVID-19 patients.<\/jats:p>","DOI":"10.1186\/s12872-020-01734-4","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T23:02:31Z","timestamp":1603062151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiology on the cutting edge: updates from the\u00a0European Society of Cardiology (ESC) Congress 2020"],"prefix":"10.1186","volume":"20","author":[{"given":"Enrique","family":"Gallego-Colon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Vecchi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cannat\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciar\u00e1n Martin","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"33","key":"1734_CR1","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1093\/eurheartj\/ehaa681","volume":"41","author":"B Casadei","year":"2020","unstructured":"Casadei B. Barbara Casadei opening at virtual ESC Annual Congress 2020. Eur Heart J. 2020;41(33):3122\u20133.","journal-title":"Eur Heart J"},{"issue":"18","key":"1734_CR2","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"E Driggin","year":"2020","unstructured":"Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1734_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1056\/NEJMc2009166","volume":"383","author":"O De Filippo","year":"2020","unstructured":"De Filippo O, D\u2019Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G, Gallone G, Verardi R, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020;383(1):88\u20139.","journal-title":"N Engl J Med"},{"issue":"22","key":"1734_CR4","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","volume":"41","author":"S De Rosa","year":"2020","unstructured":"De Rosa S, Spaccarotella C, Basso C, Calabro MP, Curcio A, Filardi PP, Mancone M, Mercuro G, Muscoli S, Nodari S, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083\u20138.","journal-title":"Eur Heart J"},{"issue":"22","key":"1734_CR5","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ, Tannenbaum M, Chambers J, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"1734_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1986","author":"A Cannata","year":"2020","unstructured":"Cannata A, Bromage DI, Rind IA, Gregorio C, Bannister C, Albarjas M, Piper S, Shah AM, McDonagh TA. Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London. Eur J Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ejhf.1986.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1734_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/FJC.0000000000000836","volume":"75","author":"DL Dixon","year":"2020","unstructured":"Dixon DL, Van Tassell BW, Vecchie A, Bonaventura A, Talasaz AH, Kakavand H, D\u2019Ascenzo F, Perciaccante A, Castagno D, Ammirati E, et al. Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19). J Cardiovasc Pharmacol. 2020;75(5):359\u201367.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1734_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612\/5899003","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612\/5899003.","journal-title":"Eur Heart J"},{"key":"1734_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612\/5899003","author":"JP Collet","year":"2020","unstructured":"Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612\/5899003.","journal-title":"Eur Heart J"},{"key":"1734_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa554","author":"H Baumgartner","year":"2020","unstructured":"Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa554.","journal-title":"Eur Heart J"},{"key":"1734_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa605","author":"A Pelliccia","year":"2020","unstructured":"Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, Collet JP, Corrado D, Drezner JA, Halle M, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa605.","journal-title":"Eur Heart J"},{"key":"1734_CR12","unstructured":"Rate Control Therapy Evaluation in Permanent Atrial Fibrillation\u2014RATE-AF. Presented by Dr. Dipak Kotecha at the European Society of Cardiology Virtual Congress, August 29, 2020. https:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2020\/08\/28\/15\/59\/rate-af. Last accessed 23 Sept 2020."},{"key":"1734_CR13","unstructured":"First randomised trial backs safety of common heart drugs in COVID-19 patients BRACE CORONA trial presented in a Hot Line Session today at ESC Congress 2020. Presented by Dr. Renato D. Lopes at the European Society of Cardiology Virtual Congress, September 1, 2020. https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/LOPES. Last accessed 21 Sept 2020."},{"key":"1734_CR14","unstructured":"PARALLAX meets one primary endpoint in heart failure with preserved ejection fraction. PARALLAX trial presented in a Hot Line Session today at ESC Congress 2020. Presented by Dr. Burkert Pieske at the European Society of Cardiology Virtual Congress, August 30th, 2020. https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/PIESKE. Last accessed 23 Sept 2020."},{"key":"1734_CR15","unstructured":"Trial clarifies which patients with acute pulmonary embolism can be managed at home. HOME-PE trial presented in a Hot Line Session today at ESC Congress 2020. Presented by Dr. Pierre-Marie Roy at the European Society of Cardiology Virtual Congress, August 31st, 2020. https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/Trial-clarifies-which-patients-with-acute-pulmonary-embolism-can-be-managed-at-home. Last accessed 23 Sept 2020."},{"key":"1734_CR16","unstructured":"Randomized Trial of Transfusion Strategies in Patients With Myocardial Infarction and Anemia\u2014REALITY. Presented by Dr. Philippe Gabriel Steg at the European Society of Cardiology Virtual Congress, September 1, 2020. https:\/\/esc2020.escardio.org\/detail\/video\/ref:S31204?_ga=2.117322051.413019163.1600901788-834326117.1596400834. Last accessed 23 Sept 2020."},{"key":"1734_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa659","author":"N Bouabdallaoui","year":"2020","unstructured":"Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, et al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa659.","journal-title":"Eur Heart J"},{"key":"1734_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1915152","author":"J Brouwer","year":"2020","unstructured":"Brouwer J, Nijenhuis VJ, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, Frambach P, De Bruyne B, van Houwelingen GK, Van Der Heyden JAS, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/nejmoa1915152.","journal-title":"N Engl J Med"},{"key":"1734_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa652","author":"MJ Budoff","year":"2020","unstructured":"Budoff MJ, Bhatt DL, Kinninger A, Lakshmanan S, Muhlestein JB, Le VT, May HT, Shaikh K, Shekar C, Roy SK, et al. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa652.","journal-title":"Eur Heart J."},{"key":"1734_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2019422.","journal-title":"N Engl J Med"},{"key":"1734_CR21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"issue":"10253","key":"1734_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396(10253):759\u201369.","journal-title":"Lancet"},{"key":"1734_CR23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2022190.","journal-title":"N Engl J Med"},{"key":"1734_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050771","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, Sriamareswaran R, Htun NM, Wilson W, Stub D, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050771.","journal-title":"Circulation"},{"issue":"21","key":"1734_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"key":"1734_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31824-9","author":"F Zannad","year":"2020","unstructured":"Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)31824-9.","journal-title":"Lancet"},{"issue":"4","key":"1734_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61(4):404\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"26","key":"1734_CR28","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"key":"1734_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa658","author":"S Haldar","year":"2020","unstructured":"Haldar S, Khan HB, Boyalla V, Kralj-Hans I, Jones S, Lord J, Onyimadu O, Satishkumar A, Bahrami T, De Souza A, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa658 (Epub ahead of print).","journal-title":"Eur Heart J."},{"issue":"1","key":"1734_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","volume":"18","author":"W Lesyuk","year":"2018","unstructured":"Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004\u20132016. BMC Cardiovasc Disord. 2018;18(1):74.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01734-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:10:35Z","timestamp":1634602235000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01734-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01734-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"19 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Bonaventura and Dr. Vecchi\u00e9 received a travel grant from Kiniksa Pharmaceuticals Ltd. to attend the 2019 AHA Scientific Sessions. The other authors report no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}